Submissions

This journal is not accepting submissions at this time.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word, or PDF document file format.
  • We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed at the end of the manuscript.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
  • Authors are kindly required to suggest at least two potential reviewers (name, affiliation and e-mail) for their manuscript in the "Comments to the Editor" field (Step 1. Submission Process).

Original Articles

Original Articles (4000 words max, abstract 180 words max, 30 references max) This type of publication should in general be divided into an abstract, introduction, design and methods, results, discussion and references. A maximum of 20 authors is permitted, and additional authors should be listed in an ad hoc appendix.

Technical Reports

Technical Reports (1000 words max, no abstract) Such publications are short methodological reports presenting relevant topics in malaria research. They report on experiences with new technologies, such as drugs, vaccines, and diagnostics, relevant to malaria. New analytical techniques to analyze data, such as mathematical or non-mathematical models or new and original ways to show results are welcome. Authors are asked to take an objective and critical view, and they should include a box that lists up advantages and disadvantages of the new technology. If the technique is a new diagnostic tool, the authors are asked for a discussion on the sensitivity and specificity of the new tool.

Reviews

Reviews (3500 words max, minimum 40 references, 5 figures and tables max) Following a short introduction, putting the area into context and defining the aim, reviews will concentrate on the most recent developments in the field. The method section of the review should comprise a description of how the studies have been selected for inclusion in the review. The discussion will address the relevance of the findings for policy makers at national and international level. A review should clearly describe the search strategy followed (keywords, inclusion, exclusion criteria, search engines,...) and the Results section needs to explain how the final set of articles was obtained. We encourage authors to follow the guidelines at: http://www.prisma-statement.org/

Views and Comments

Views and Comments (1500 words max, minimum 15 references) They are opinion pieces grounded in evidence. Authors are encouraged to cite up to 15 references in support of their key assertions, and to use a logical structure for their piece.

Policy Platform Articles

Policy Platform Articles (1500 words max, minimum 25 references) They provide a platform to discuss specific policies that could improve the lives of those at risk of, or affected by, Malaria. New and specific policy proposals that arise from high-level national or international meetings will be considered for this section, but we will not consider traditional "meeting reports".

Country Reports

Country Reports (1500 words max) This publication is a special type of Review paper, which describes the current situation in a country focusing on e.g. surveillance systems, control methods. The method section of the review should comprise a description of how the studies have been selected for inclusion in the paper. The discussion will address the relevance of the findings for policy makers at national and international level.

Letters to the Editor

Letters to the Editor (800 words max) are invited, short essays that express the author’s viewpoint, may respond to published manuscripts in our journal or deliver information or news regarding an issue related to the Journal scope. If the letter is in relation to a published manuscript, the authors of the original manuscript will be given the opportunity to provide a rebuttal. Authors of Letters to the Editor should provide a short title for their letter.

Book Reviews

Book Reviews on recent titles in the area of malaria research are welcomed. They should be short critical analysis and evaluation of the quality, meaning, and significance of a book which addressed at least one of main topics of the Journal. The contents of this rubric are referenced in the table of contents and can therefore be cited.

Privacy Statement

Privacy is an important concern for users of our site, and is something that PAGEPress takes very seriously. Below you will find our policy for protecting users' personal information. Registration on our website is optional and voluntary. Browsing and viewing articles on our website does not require any personal information to be submitted from users. Nor do these functions require the user's browser to be set to accept cookies. Some other aspects of our services published on our website do require the use of cookies, and the supply of information such as name, e-mail etc. This is necessary for security reasons and also for us to be able to assure standards of scientific integrity. Users may submit further personal information (e.g. details of research areas of interest) in order to take advantage of present and future personalization facilities on our website. In accordance with European Union guidelines, registrants may decline to provide the information requested. They should be advised, however, that PAGEPress may be unable to deliver its services unless at least the information necessary for security and identification purposes is provided. In order to offer the best possible service to users, PAGEPress tracks the patterns of usage of pages on the site. This enables us to identify the most popular articles and services. Where users have provided details of their research areas of interest, this information can be correlated, helping PAGEPress to provide a useful service for scientists, offering them the most relevant information based on their areas of interest. User information will only be shared with third parties with the explicit consent of the user. Publishing a scientific manuscript is inherently a public (as opposed to anonymous) process. The name and e-mail address of all authors of a PAGEPress manuscript will be available to users of PAGEPress. These details are made available in this way purely to facilitate scientific communication. Collecting these e-mail addresses for commercial use is not allowed, nor will PAGEPress itself send unsolicited e-mail to authors, unless it directly concerns the paper they have published on PAGEPress journals. PAGEPress reserves the right to disclose members' personal information if required to do so by law, or in the good faith and belief that such action is reasonably necessary to comply with legal process, respond to claims, or protect the rights, property or safety of PAGEPress, employees or members.